2019 ◽
Vol 22
◽
pp. S468-S469
F. Diamantogiannis
◽
P. Viktoratos
◽
J. May
◽
B. Malcolm
◽
Van de Wetering G
◽
...
2016 ◽
Vol 19
(7)
◽
pp. A735
◽
ME Romero Prada
◽
LM Huerfano
◽
NC Roa Cardenas
2009 ◽
Vol 12
(7)
◽
pp. A495
◽
JI Godoy
◽
AF Cardona
◽
HA Caceres
◽
JM Otero
◽
M Lujan
◽
...
2012 ◽
Vol 15
(4)
◽
pp. A219
S.M. Nuñez
◽
J.I. Godoy
◽
A.F. Cardona
◽
J.M. Otero
◽
M. Lujan
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. e15136-e15136
N. Topibulpong
◽
S. Tanasanvimon
◽
N. Parinyanitikul
◽
C. Vinayanuwattikun
◽
V. Sriuranpong
Stefano Capri
◽
Camillo Porta
◽
Claudia Condorelli
◽
Eleonora Premoli
◽
Ankur Khare
◽
...
Rebecca Shay
◽
Andrew Nicklawsky
◽
Dexiang Gao
◽
Elaine T. Lam
C. Polanco Sánchez
◽
F. Pérez-Alcántara
◽
J. May
◽
K.M. Gooden
◽
B. Malcolm
◽
...
S. Branchoux
◽
S. Négrier
◽
C. de Peretti
◽
B. Malcolm
◽
J. May
◽
...
2010 ◽
Vol 13
(7)
◽
pp. A513
◽
N Topibulpong
◽
S Tanasanvimon
◽
N Parinyanitikul
◽
C Vinayanuwattikun
◽
V Sriuranpong
S Pruis
◽
F Pearce
◽
MI Abdul Aziz
◽
DB Wu
◽
KH Ng
Close
Export Citation Format
Close
Share Document
Close
PCN169 COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE FIRST-LINE TREATMENT OF ADVANCED/METASTATIC RENAL CELL CARCINOMA IN GREECE
